Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126402701 | 12640270 | 1 | I | 20160718 | 20160802 | 20160810 | 20160810 | EXP | GB-MHRA-EYC 00143036 | GB-ACTAVISPR-2016-17203 | WATSON | 57.00 | YR | M | Y | 80.00000 | KG | 20160810 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126402701 | 12640270 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG, UNKNOWN | UNCONFIRMED | 77663 | 50 | MG | UNK | ||||||
| 126402701 | 12640270 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126402701 | 12640270 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126402701 | 12640270 | 4 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126402701 | 12640270 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 126402701 | 12640270 | 6 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126402701 | 12640270 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126402701 | 12640270 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126402701 | 12640270 | 1 | Anxiety |
| 126402701 | 12640270 | 2 | Product used for unknown indication |
| 126402701 | 12640270 | 3 | Product used for unknown indication |
| 126402701 | 12640270 | 4 | Product used for unknown indication |
| 126402701 | 12640270 | 5 | Product used for unknown indication |
| 126402701 | 12640270 | 6 | Product used for unknown indication |
| 126402701 | 12640270 | 7 | Product used for unknown indication |
| 126402701 | 12640270 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126402701 | 12640270 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126402701 | 12640270 | Hot flush | |
| 126402701 | 12640270 | Hyperhidrosis | |
| 126402701 | 12640270 | Malaise | |
| 126402701 | 12640270 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126402701 | 12640270 | 1 | 20160718 | 0 |